LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$16.80
-0.69 (-3.95%)
▼
5d:
-3.5%
30d:
-12.86%
90d:
-26.44%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LEGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: LEGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$54.53
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$33.86
50.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $16.80, which is considered oversold relative to its 30-day fair value range of $17.68 to $19.34. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.0) compared to its historical average (55.5). Remarkably, the market is currently pricing in an annual earnings decline of 35.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is in a strong downtrend. The price is currently testing key support at $16.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: LEGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $58.09 (+245.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LEGN is in a strong downtrend. The price is currently testing key support at $16.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: LEGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $58.09 (+245.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$17.68 -
$19.34
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 245.8% below Wall St target ($58.09)
Fair Price Analysis
30-Day Fair Range
$17.68 -
$19.34
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$16.96
Resistance Level
$19.27
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.00
Wall Street Target
$58.09
(+245.8%)
Revenue Growth (YoY)
64.2%
Profit Margin
-28.8%
Valuation Discount vs History
-35.4% cheaper
PE vs Historical
15.0 vs 55.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-35.4%
(market-implied from PE analysis)
1-Year Target
$15.12
(-10%)
2-Year Target
$13.61
(-19%)
3-Year Target
$12.25
(-27%)
3-Yr Target (if PE normalizes)
(PE: 15→56)
$45.31
(+170%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 998.0%)
$84.67
(+404%)
Base:
(SPY PE: 15.0, Growth: 998.0%)
$56.70
(+238%)
Bear:
(PE: 12.8, Growth: 998.0%)
$48.20
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.0 to 55.5
Stabilization Target:
$62.16
(+270.0%)
PE Expansion Potential:
+270.0%
Share & Embed Analysis
Last updated: March 30, 2026 7:03 AM ET
Data refreshes hourly during market hours. Next update: 8:03 AM
Data refreshes hourly during market hours. Next update: 8:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 47 HOLD |
